---

---

symbols : Amgn    crawled time : 09:00   

save search

---

Enzyme-linked immunosorbent assay (Elisa) testing market size to Increase by USD 564.97 million between 2022-2027, Technavio
Published: 2024-04-01 (Crawled : 09:00) - prnewswire.com
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| -5.54% | O: -1.99% H: 0.45% C: 0.33%
million market

---

Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
Published: 2024-01-29 (Crawled : 09:00) - globenewswire.com
ALVO | $13.33 0.83% 0.75% 170K |

n/a

| -9.01% | O: 2.39% H: 4.67% C: 1.67%
KMDA | $5.1 0.99% -0.99% 8K |

Health Technology

| -9.58% | O: -1.05% H: 0.41% C: -0.35%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| -12.79% | O: -0.11% H: 0.7% C: 0.65%
avt03 prolia biosimilar positive results study

---

Biosimilars market size to increase by USD 42.22 billion | The regulatory landscape regarding therapeutic interchangeability across different countries is the market trend - Technavio
Published: 2023-11-01 (Crawled : 09:00) - prnewswire.com
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 18.42% | O: 0.06% H: 1.3% C: 0.43%
BIIB | $194.11 -0.14% -0.15% 930K |

Health Technology

| -18.28% | O: 0.43% H: 1.05% C: 0.44%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| 6.34% | O: 0.22% H: 1.92% C: 1.78%
market

---

Large Molecule Injectable Drugs Market to grow by USD 191.45 billion from 2022-2027 | North America to account for 45% of market growth - Technavio
Published: 2023-09-18 (Crawled : 09:00) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| 9.73% | O: 2.7% H: 0.0% C: -5.11%
AZNCF | News | $138.73 1.86% -4.19% 3.6K |

Health Technology

| 0.33% | O: -2.01% H: 1.73% C: -2.99%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 11.35% | O: -0.05% H: 0.0% C: -1.31%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| -7.66% | O: 0.06% H: 0.09% C: -0.6%
MDT | $80.57 1.37% 0.0% 3.8M |

Health Technology

| -1.47% | O: 0.59% H: 1.69% C: 0.67%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| 8.44% | O: 0.72% H: 0.13% C: -0.93%
BAX | $40.4 2.36% 1.14% 3.3M |

Health Technology

| 3.38% | O: -0.13% H: 0.28% C: -0.77%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 9.98% | O: 0.33% H: 0.0% C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -15.86% | O: -1.29% H: 0.0% C: 0.0%
BIIB | $194.11 -0.14% -0.15% 930K |

Health Technology

| -23.82% | O: 0.06% H: 0.44% C: -0.64%
AZN | News | $70.13 2.31% 2.24% 4.3M |

Health Technology

| 2.72% | O: -0.76% H: 0.16% C: -1.65%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| 4.29% | O: 1.02% H: 0.7% C: -0.09%
america growth market

---

Nanotechnology Drug Delivery Market to Reach $209.5 Billion, Globally, by 2032 at 9.1% CAGR: Allied Market Research
Published: 2023-07-19 (Crawled : 09:00) - prnewswire.com
AZNCF | News | $138.73 1.86% -4.19% 3.6K |

Health Technology

| 3.18% | O: 0.47% H: 1.47% C: 1.47%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 9.52% | O: -1.97% H: 0.0% C: 0.0%
TEVA | $12.88 0.16% 0.0% 7.9M |

Health Technology

| 58.43% | O: 1.23% H: 4.13% C: 4.01%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| -8.4% | O: 0.61% H: 0.6% C: -0.84%
BMY | $49.14 0.43% 0.12% 6.4M |

Health Technology

| -20.74% | O: 0.19% H: 1.19% C: -0.1%
AZN | News | $70.13 2.31% 2.24% 4.3M |

Health Technology

| 5.03% | O: 1.5% H: 0.75% C: -0.32%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| 16.92% | O: 0.18% H: 0.67% C: -0.4%
drug reach research market

---

Atherosclerosis Drugs Market to Reach $27.7 Billion, Globally, by 2032 at 3.0% CAGR: Allied Market Research
Published: 2023-05-23 (Crawled : 09:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 12.59% | O: -1.22% H: 0.0% C: -0.62%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| -5.93% | O: 0.74% H: 0.0% C: -1.22%
JNJ | News | $149.12 0.82% 0.3% 7.2M |

Health Technology

| -4.94% | O: 0.15% H: 0.74% C: -0.18%
BHC | $8.45 -2.76% 0.0% 2.4M |

Health Technology

| -3.98% | O: -2.27% H: 4.24% C: -2.21%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -14.86% | O: -0.01% H: 0.0% C: 0.0%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| 21.39% | O: 0.1% H: 1.16% C: 0.1%
reach research market

---

Alvotech Reports Financial Results for First three Months of 2023 and Provides Business Update
Published: 2023-05-19 (Crawled : 09:00) - globenewswire.com
ALVO | $13.33 0.83% 0.75% 170K |

n/a

| 60.99% | O: 8.94% H: 0.0% C: -7.65%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| -5.56% | O: -0.36% H: 1.01% C: 0.82%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 17.05% | O: 0.29% H: 1.35% C: 0.87%
REGN | News | $899.71 0.32% 0.32% 340K |

Health Technology

| 20.43% | O: 0.64% H: 1.56% C: 0.9%
KMDA | $5.1 0.99% -0.99% 8K |

Health Technology

| 9.26% | O: 2.31% H: 1.86% C: -0.2%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| 21.26% | O: 0.09% H: 0.64% C: -0.45%
business update financial results

---

CANbridge Pharmaceuticals Appoints Jason West Vice President, Head of Gene Therapy Research
Published: 2023-05-05 (Crawled : 09:00) - biospace.com/
CRSP | News M | $55.66 1.11% 1.17% 940K |

Health Technology

| 4.78% | O: 1.88% H: 6.97% C: 3.09%
BIIB | $194.11 -0.14% -0.15% 930K |

Health Technology

| -38.1% | O: 0.08% H: 1.89% C: 1.35%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| 17.26% | O: 0.33% H: 1.88% C: 1.66%
west pharmaceuticals research therapy

---

Vaccentis Appoints Dr. Ingrid Rauter as Chief Medical Officer and Head of Research & Development
Published: 2023-05-03 (Crawled : 09:00) - biospace.com/
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| 15.23% | O: 0.0% H: 0.14% C: -2.82%
research medical

---

Bassem Elmankabadi, M.D. joins Foresee Pharmaceuticals as a Senior Vice President of Clinical Development
Published: 2023-04-17 (Crawled : 09:00) - prnewswire.com
FGEN | $1.14 -0.87% -1.77% 800K |

Health Technology

| -94.19% | O: 0.36% H: 5.13% C: 4.52%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| 8.76% | O: 0.36% H: 0.24% C: -1.12%
pharmaceuticals

---

Breast cancer therapeutics market size grow by USD 13.85 billion between 2021 to 2026; AbbVie Inc. and Amgen Inc., among others, emerge as key vendors - Technavio
Published: 2023-04-13 (Crawled : 09:00) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| 9.43% | O: 0.54% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -18.15% | O: -1.1% H: 0.0% C: 0.0%
AZNCF | News | $138.73 1.86% -4.19% 3.6K |

Health Technology

| -5.79% | O: 0.0% H: 1.63% C: 1.63%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 18.52% | O: 1.25% H: 0.51% C: 0.51%
VTRS | News A | $11.235 -0.13% -0.13% 5.1M |

Health Technology

| 14.56% | O: 0.31% H: 1.42% C: 0.71%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| -1.76% | O: 1.3% H: 0.56% C: 0.51%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| 7.64% | O: 0.85% H: 0.76% C: 0.76%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 3.41% | O: -0.84% H: 1.16% C: 1.05%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -17.25% | O: 0.29% H: 0.0% C: 0.0%
PBYI | $5.17 3.19% 3.09% 270K |

Health Technology

| 77.66% | O: -0.34% H: 10.17% C: 6.9%
AZN | News | $70.13 2.31% 2.24% 4.3M |

Health Technology

| -4.92% | O: 0.39% H: 1.05% C: 0.97%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| 8.98% | O: -0.36% H: 1.33% C: 1.14%
abbvie breast cancer therapeutics market

---

Notice of Annual general meeting in Swedish Orphan Biovitrum AB (publ)
Published: 2023-03-30 (Crawled : 09:00) - prnewswire.com
VRNA | $15.75 0.19% 0.19% 460K |

Health Technology

| -22.1% | O: 0.89% H: 0.54% C: -3.05%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| 12.81% | O: 0.62% H: 0.12% C: -0.42%
meeting

---

Global Peptide Therapeutics Market to Grow by USD 23.36 Bn, Collaboration for research and development to be the Key Trend - Technavio
Published: 2022-11-02 (Crawled : 09:00) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| 23.89% | O: 3.27% H: 2.19% C: -3.32%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 3.92% | O: -2.21% H: 0.0% C: -0.14%
AZNCF | News | $138.73 1.86% -4.19% 3.6K |

Health Technology

| 17.47% | O: 0.8% H: 1.45% C: 0.81%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| 16.91% | O: 0.63% H: 0.61% C: -1.2%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| 21.31% | O: 1.91% H: 0.0% C: -2.87%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| 7.12% | O: 0.07% H: 0.0% C: 0.0%
AZN | News | $70.13 2.31% 2.24% 4.3M |

Health Technology

| 17.18% | O: 0.75% H: 1.66% C: -1.0%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| -0.06% | O: -0.15% H: 1.19% C: -0.97%
research global collaboration therapeutics market

---

Women's Health Therapeutics Market Size to Grow by USD 30.35 billion, Rising Awareness about Gynecological Diseases to be a Key Trend - Technavio
Published: 2022-09-27 (Crawled : 09:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 50.76% | O: -0.91% H: 0.0% C: -2.68%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| 27.02% | O: 1.29% H: 0.42% C: -1.22%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 18.89% | O: 0.98% H: 2.07% C: -0.61%
ABT | News | $107.07 -0.2% -0.09% 3.8M |

Health Technology

| 7.24% | O: 0.41% H: 0.48% C: -1.92%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| 24.23% | O: 0.62% H: 0.0% C: 0.0%
OBSV | $0.1018 -15.52% -18.95% 8.2M |

Health Technology

| -28.76% | O: 0.0% H: 4.97% C: -1.89%
ICLR | News | $297.93 3.37% 3.33% 780K |

Health Technology

| 62.16% | O: 0.61% H: 1.41% C: -0.87%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| 19.85% | O: 0.04% H: 1.32% C: -0.43%
health therapeutics market

---

LUMAKRAS® (SOTORASIB) COMBINED WITH VECTIBIX® (PANITUMUMAB) SHOWS CONFIRMED 30% OBJECTIVE RESPONSE RATE IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER
Published: 2022-09-12 (Crawled : 09:00) - prnewswire.com
MS | News 0 d | $92.09 1.58% 0.07% 4.9M |

Finance

| 2.94% | O: 0.6% H: 1.16% C: 0.17%
CCXI | News | $51.99 -0.04% |

Health Technology

| 0.85% | O: -0.16% H: 0.16% C: 0.06%
BGNE | $130.94 1.1% 1.24% 130K |

Health Technology

| -23.3% | O: -1.88% H: 3.78% C: 3.73%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| 9.78% | O: -3.91% H: 1.55% C: -0.16%
lumakras response cancer

---

Rheumatoid Arthritis Drugs Market Size to Grow by USD 14.90 Billion | 37% of the growth will originate from Europe | Technavio
Published: 2022-06-24 (Crawled : 09:00) - prnewswire.com
ALPMF | News | $9.75 6.33% 43.47% 52 |

Health Technology

| -38.11% | O: 0.99% H: 0.0% C: -0.5%
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| -22.02% | O: 3.19% H: 2.28% C: -1.81%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -4.19% | O: 8.01% H: 0.0% C: 0.0%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 44.84% | O: 6.71% H: 0.0% C: -0.1%
ALPMY | News | $9.53 0.32% -1.11% 690K |

Manufacturing

| -40.14% | O: 4.33% H: 0.0% C: -2.44%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| 16.16% | O: 2.38% H: 0.0% C: 0.0%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| -24.04% | O: 1.26% H: 0.95% C: 0.92%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 13.13% | O: 1.57% H: 0.0% C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -8.66% | O: 3.49% H: 0.0% C: 0.0%
GLMD | $0.3641 -2.33% -0.41% 64K |

Health Technology

| -99.68% | O: 1.21% H: 0.0% C: -3.5%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| 11.86% | O: 0.37% H: 0.82% C: 0.56%
europe growth market drug

---

Atherosclerosis Therapeutics Market Size to Grow by USD 3.44 billion | Increasing Risk Factors for Atherosclerosis to Boost Growth | Technavio
Published: 2022-04-11 (Crawled : 09:00) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| -13.25% | O: 22.86% H: 0.0% C: -1.09%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -17.18% | O: 3.07% H: 0.0% C: -0.32%
AZNCF | News | $138.73 1.86% -4.19% 3.6K |

Health Technology

| -1.55% | O: -2.11% H: 0.0% C: 0.0%
VTRS | News A | $11.235 -0.13% -0.13% 5.1M |

Health Technology

| 1.9% | O: -0.36% H: 0.18% C: -2.73%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| 2.2% | O: 1.48% H: 0.17% C: -0.37%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| -12.24% | O: 1.51% H: 0.0% C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -16.46% | O: 4.5% H: 0.0% C: 0.0%
AZN | News | $70.13 2.31% 2.24% 4.3M |

Health Technology

| -1.42% | O: -0.21% H: 0.41% C: -0.51%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| 7.89% | O: 0.63% H: 1.91% C: -1.08%
risk therapeutics growth market

---

Brain Tumor Therapeutics Market to Record 9.10% Y-O-Y Growth Rate in 2021 | Amgen Inc. and Bristol-Myers Squibb Co. Among Key Vendors | Technavio
Published: 2022-01-19 (Crawled : 09:00) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| -13.24% | O: -1.71% H: 0.22% C: -1.8%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 7.2% | O: -0.14% H: 0.0% C: 0.0%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| 5.95% | O: -0.6% H: 0.0% C: 0.0%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| -12.43% | O: -0.84% H: 0.0% C: 0.0%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| 16.16% | O: -0.15% H: 0.0% C: 0.0%
therapeutics growth train

---

LUMAKRAS™ (Sotorasib) Combined With Vectibix® (Panitumumab) Showed Encouraging Efficacy And Safety In Patients With KRAS G12C-Mutated Colorectal Cancer
Published: 2021-09-16 (Crawled : 09:00) - prnewswire.com
BGNE | $130.94 1.1% 1.24% 130K |

Health Technology

| -65.11% | O: 1.72% H: 1.18% C: 0.9%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| 24.66% | O: -0.05% H: 0.29% C: -0.3%
cancer colorectal cancer

---

New Data At ESC Congress 2021 Shows Repatha® (evolocumab) Improves Features Of Plaque Stability In Patients With Acute Coronary Syndrome (ACS)
Published: 2021-08-27 (Crawled : 09:00) - prnewswire.com
BGNE | $130.94 1.1% 1.24% 130K |

Health Technology

| -53.7% | O: 1.71% H: 0.22% C: -1.97%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| 22.78% | O: 0.34% H: 1.41% C: 0.25%
syndros plague

---

Gainers vs Losers

74%

26%

Top 10 Gainers

MTTR | News M | $4.8 175.86% 63.6% 71M |

AGBA | $2.5 100.0% 56.6% 200M |

Finance

MLEC | $2.47 76.43% 42.62% 78M |

n/a

EDBL | News | $6.26 66.49% 40.13% 16M |

ATGL | $2.86 46.25% 32.8% 180K |

ZAPP | $0.2175 47.16% 32.05% 16M |

n/a

ONFO | $0.6075 38.38% 27.74% 7.3M |

n/a

VIVK | $1.48 38.32% 27.7% 530K |

Professional, Scientific, and T...

MNTS | $0.5 35.69% 26.3% 4.7M |

SDIG A | $3.635 35.13% 26.0% 1M |

---

Your saved searches

---